Andrew Retter - 15 Aug 2025 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role
Chief Medical Officer
Signature
/s/ Andrew Retter
Issuer symbol
VNRX
Transactions as of
15 Aug 2025
Transactions value $
$0
Form type
4
Filing time
19 Aug 2025, 16:06:00 UTC
Previous filing
05 Aug 2025
Next filing
04 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Retter Andrew Chief Medical Officer 1489 WEST WARM SPRINGS ROAD,, SUITE 110, HENDERSON /s/ Andrew Retter 19 Aug 2025 0002015252

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Award $0 +19.5K +14.83% $0.00 151K 15 Aug 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 15, 2025, the reporting person was awarded 19,524 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two equal installments of 9,762 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date.